Slideshow

OSA and Dyslipidemia: Beyond the Obesity Factor

Author(s):

Veronica Hackethal MD

Obstructive sleep apnea negatively impacts lipid levels, greatly increasing risk for CV disease and independent of obesity, according to the largest analysis of the link to date.

Related Videos
Transformations in Aortic Disease Management with Mehrdad Ghoreishi, MD | Image Credit: Baptist Health South Florida
Experts' Perspectives: Top Stories in Cardiology for 2024
Nathan D. Wong, MD, PhD: Growing Role of Lp(a) in Cardiovascular Risk Assessment | Image Credit: UC Irvine
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
The APAC Recap: Dyslipidemia at CAPP Live 2024 with Viet Le, DMSc, PA-C | Image Credit: APAC
HCPLive Lipoprotein Apheresis Special Report thumbnail
HCPLive Lipoprotein Apheresis Special Report thumbnail
HCPLive Lipoprotein Apheresis Special Report thumbnail
Related Content
FDA Approves Chenodiol Tablets for Cerebrotendinous Xanthomatosis | Image Credit: US Food and Drug Administration
February 21st 2025

FDA Approves Chenodiol Tablets for Cerebrotendinous Xanthomatosis

Connor Iapoce
Prof. Kausik Ray: Inclisiran Data at ESC Congress 2020
September 3rd 2020

Prof. Kausik Ray: Inclisiran Data at ESC Congress 2020

Patrick Campbell
Sotagliflozin Cuts MACE Risk By 23% in Patients with Type 2 Diabetes, CKD | Image Credit: Mount Sinai
February 18th 2025

Sotagliflozin Cuts MACE Risk By 23% in Patients with Type 2 Diabetes, CKD

Connor Iapoce
The State of Preventive Cardiology
August 28th 2020

The State of Preventive Cardiology

Kevin Kunzmann
The HCPFive: Top News for Healthcare Providers from the Week of 02/09 | Image Credit: HCPLive
February 16th 2025

The HCPFive: Top News for Healthcare Providers from the Week of 02/09

Connor Iapoce
Patient Enrollment Low in Cardiovascular Clinical Trials in the US | Image Credit: Baylor Scott and White Health
February 14th 2025

Patient Enrollment Low in Cardiovascular Clinical Trials in the US

Connor Iapoce
© 2025 MJH Life Sciences

All rights reserved.